DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Share Price

Certificat

DE000ME9LNE2

Real-time Bid/Ask 08:09:43 12/06/2024 pm IST
0.177 EUR / 0.185 EUR +2.84% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS
Current month-43.23%
1 month-51.11%
Date Price Change
12/24/12 0.19 +7.95%
11/24/11 0.176 -10.66%
10/24/10 0.197 -24.23%
07/24/07 0.26 -3.70%
06/24/06 0.27 0.00%

Delayed Quote Börse Stuttgart

Last update June 12, 2024 at 06:23 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN ME9LNE
ISINDE000ME9LNE2
Date issued 05/03/2024
Strike 90 $
Maturity 20/12/2024 (191 Days)
Parity 10 : 1
Emission price 0.28
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.48
Lowest since issue 0.175
Spread 0.008
Spread %4.02%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
65.82 USD
Average target price
89.35 USD
Spread / Average Target
+35.76%
Consensus